Skip to main content

Advertisement

Table 2 QALYs gained from key musculoskeletal disease interventions, 1994–2013

From: Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes

  Rheumatoid arthritis (M00–06) Psoriatic arthritis (M07) Juvenile idiopathic arthritis (M08–09) Gout
(M10–12)
Osteoarthritis (M15–19) Connective tissue disorders (M30–35) Ankylosing spondylitis (M45) Low back pain (M54.5) Osteoporosis (M80–82) Total QALYs
1994 698 67 205 1009 1944 6 0 534 0 4464
1995 1181 113 346 1015 2135 7 0 619 287 5703
1996 1786 171 523 1021 2825 8 0 882 287 7504
1997 2513 241 736 1027 3520 10 0 1171 458 9675
1998 3363 322 986 1033 4219 11 0 1468 572 11,973
1999 4964 499 1270 1038 4736 19 33 1624 853 15,036
2000 6449 641 1705 1089 5249 29 33 1847 915 17,957
2001 8459 845 2288 1128 7010 46 51 2070 1749 23,644
2002 9657 956 2641 1183 9500 63 46 2267 2400 28,713
2003 11,409 1137 3146 1245 11,737 85 69 2499 3663 34,990
2004 14,474 1457 4090 1309 14,454 109 197 2795 5022 43,907
2005 13,976 1454 4053 1157 11,504 106 212 2765 5974 41,201
2006 17,450 1361 3769 1135 11,652 129 154 2747 6833 45,229
2007 19,551 1858 5321 1260 12,929 156 367 2786 7921 52,149
2008 23,730 2381 6309 1493 13,386 181 392 4288 8955 61,116
2009 28,588 2662 7756 1471 13,383 195 482 5741 10,252 70,529
2010 33,882 3071 8945 1592 14,451 219 577 6999 11,994 81,729
2011 45,401 4007 11,994 1797 14,625 169 708 8546 12,538 99,786
2012 51,586 4453 13,422 1885 14,726 125 809 8385 13,111 108,502
2013 50,407 4813 13,248 2143 15,153 128 853 8212 12,875 107,834
Total 349,523 32,507 92,753 26,032 189,136 1801 4983 68,245 106,660 871,693
Value £8738 m £813 m £2,319 m £651 m £4728 m £45 m £125 m £1706 m £2667 m £21,791 m